This website is intended for UK healthcare professionals only

Nubeqa Patient Case Studies

Bayer has collaborated with healthcare professionals to develop a series of patient case studies. These case studies were developed as a promotional educational resource and share the real-world experience of expert healthcare professionals in the management of their patients with high-risk non-metastatic castration resistant prostate cancer (nmCRPC) across the whole patient journey, from initial diagnosis and treatment decisions to their management today.


These case studies share a range of different patient profiles including different ages, treatment histories, concomitant medications and outcomes to help visualise and identify patients with high-risk nmCRPC who may be suitable for treatment with NUBEQA.


Nubeqa Patient Case Study: a clinical nurse specialist perspective

Video title

YYMMDD Author/Uploaded by

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua.

By Ms Debbie Victor, Winner of BAUN 2021 Nurse of the Year, Uro-oncology Cancer Nurse Specialist, Royal Cornwall Hospitals NHS Trust


Patient: 60 years with some comorbidities and concomitant meds. Hobbies include going to the gym.


Treatment goal: Provide emotional support for PSA anxiety

This patient case study is initiated and funded by Bayer plc. No patient identifiable data or photos of patients are shared within these case studies and the appropriate consent from the patients was collected by the HCP prior to development. Individual responses and experiences to medicinal products may vary.


Ms Debbie Victor

Ms Debbie Victor

Uro-Oncology Clinical Nurse Specialist, Royal Cornwall Hospital.


Debbie Victor has received advisory and speaker fees from Astellas, Pfizer, Bayer and Ipsen.

Click below to view other Nubeqa Patient Case Studies:

Want to stay in touch?

If you would like us to keep you up to date with details of future webinars and other important news updates, please stay connected using the button below.


Report Adverse Events
Adverse events should be reported. Reporting forms and information can be found at or search MHRA Yellow Card in Google Play or Apple App Store. Adverse events should also be reported to Bayer plc Tel: 01182 063 500, Fax: 01182 063 703, Email:


If You Want to Report a Quality Complaint
Please report any quality complaint to Bayer Plc Email: For more information on how we process any personal data you share with us in relation to the above please see our Privacy Policy.